RNS with the CEO saying they are "delighted". Clearly extremely good news.13 Apr 2023 14:28
The client:-
Crescendo Biologics is located in Cambridge, UK, and is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda and Quan Capital.
IMHO the results next week would have to be appauling for the 17.25p currect sp level to fall further.
All IMHO.